» Articles » PMID: 32269618

Contrast-enhanced CT Imaging for the Assessment of Lymph Node Status in Patients with Colorectal Cancer

Overview
Journal Oncol Lett
Specialty Oncology
Date 2020 Apr 10
PMID 32269618
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to identify a novel strategy that predicts the metastatic status of lymph nodes (LNs) in patients diagnosed with colorectal cancer, using detailed characteristics of contrast-enhanced CT scan images. A total of 284 preoperative CT scans derived from patients diagnosed with colorectal cancer at Second Affiliated Hospital, Zhejiang University School of Medicine between January 2013 and July 2018 were retrospectively reviewed. A total of 794 LNs were assessed for size, margins, morphology and subtle internal enhancements in the equilibrium phase. Imaging features were analyzed by two abdominal radiologists (Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine and Departments of Radiology; Shaoxing Second Hospital Departments of Radiology, Shaoxing Second Hospital) in a blind manner. If the conclusions were not concordant, the final score was determined by a senior radiologist who specialized in abdominal radiology for ≥30 years. According to the histopathology results, 27.3% (217/794) of LNs were metastatic (LN+). In addition, LNs >10 mm in size demonstrated sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs) of 47.0, 80.9, 48.1 and 80.2%, respectively [odds ratio (OR), 3.77; 95% confidence interval (CI), 2.69-5.28]. LNs in the shape of a kidney bean (middle fat depression like kidney) and/or those with an oblong shape were more likely to be metastasis negative LNs (LN-), while lobulated and irregular LNs were more likely to be LN+. In magnified images, internal enhancement characteristics of LN- were defined as homogeneous, spotted, striped and core enhancing. By contrast, rim and heterogeneity enhancement features for LN+ demonstrated sensitivity, specificity, PPVs and NPVs of 46.5, 89.9, 63.5 and 81.7%, respectively (OR, 7.79; 95% CI, 5.33-11.40). The results demonstrated that the internal enhancement features of LNs may be used as a predictor of metastasis. The detailed benign characteristics, such as homogeneity, spotted, striped and core enhancement of LNs may facilitate the identification of LN- in patients with colorectal cancer.

Citing Articles

Radiological Assessment of Different Retroperitoneal Lymph Node Measurements in Stage 1 Testicular Cancer Patients: Impact on Clinical Stage and Treatment.

Strauch A, Nestler K, Schoch J, Kubitscheck L, Waldeck S, Schmelz H J Clin Med. 2024; 13(18).

PMID: 39337038 PMC: 11432456. DOI: 10.3390/jcm13185553.


The Diagnostic Impact of Contrast-Enhanced Computed Tomography (CECT) in Evaluating Lymph Node Involvement in Colorectal Cancer: A Comprehensive Review.

Inamdar A, Shinde R Cureus. 2024; 16(6):e61832.

PMID: 38975400 PMC: 11227440. DOI: 10.7759/cureus.61832.


Dual-Energy CT Material Decomposition: The Value in the Detection of Lymph Node Metastasis from Breast Cancer.

Yel I, DAngelo T, Gruenewald L, Koch V, Golbach R, Mahmoudi S Diagnostics (Basel). 2024; 14(5).

PMID: 38472939 PMC: 10930895. DOI: 10.3390/diagnostics14050466.


In-House Validated Map of Lymph Node Stations in a Prospective Cohort of Colorectal Cancer: A Tool for a Better Preoperative Staging.

Simu P, Jung I, Banias L, Fulop Z, Bara T, Simu I J Oncol. 2022; 2022:1788004.

PMID: 35345517 PMC: 8957432. DOI: 10.1155/2022/1788004.


Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography.

Sun X, Niwa T, Ozawa S, Endo J, Hashimoto J Acta Radiol. 2020; 63(1):3-10.

PMID: 33325727 PMC: 9530532. DOI: 10.1177/0284185120980144.

References
1.
Chi Y, Zhang X, Li J, Sun Y . To be or not to be: significance of lymph nodes on pretreatment CT in predicting survival of rectal cancer patients. Eur J Radiol. 2009; 77(3):473-7. DOI: 10.1016/j.ejrad.2009.09.016. View

2.
Rollven E, Abraham-Nordling M, Holm T, Blomqvist L . Assessment and diagnostic accuracy of lymph node status to predict stage III colon cancer using computed tomography. Cancer Imaging. 2017; 17(1):3. PMC: 5248480. DOI: 10.1186/s40644-016-0104-2. View

3.
Abdel-Nabi H, Doerr R, Lamonica D, Cronin V, Galantowicz P, Carbone G . Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998; 206(3):755-60. DOI: 10.1148/radiology.206.3.9494497. View

4.
Doyon F, Attenberger U, Dinter D, Schoenberg S, Post S, Kienle P . Clinical relevance of morphologic MRI criteria for the assessment of lymph nodes in patients with rectal cancer. Int J Colorectal Dis. 2015; 30(11):1541-6. DOI: 10.1007/s00384-015-2339-y. View

5.
Brown G, Richards C, Bourne M, Newcombe R, Radcliffe A, Dallimore N . Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003; 227(2):371-7. DOI: 10.1148/radiol.2272011747. View